mAbs targeting muscarinic acetylcholine receptor M3 (Juno)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamemAbs targeting muscarinic acetylcholine receptor M3 (Juno)
Drug Alias Namemonoclonal antibodies targeting muscarinic acetylcholine receptor M3 (X-BODY BioSciences)mAbs targeting muscarinic acetylcholine receptor M3 (X-BODY BioSciences)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonists
TargetsMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesX-BODY BioSciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesX-BODY BioSciencesJuno Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A